Navigation Links
Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder
Date:9/21/2010

antee that SOM230 will be submitted or approved for sale in any market, or for any particular indication, or at any particular time. Nor can there be any guarantee that SOM230 will achieve any particular levels of revenue in the future. In particular, management's expectations regarding SOM230 could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, the Novartis Group offers a diversified portfolio to best meet these needs: innovative medicines, preventive vaccines, diagnostic tools, cost-saving generic pharmaceuticals and consumer health products. The Novartis Group is the only company with
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 /PRNewswire/ ... MXIM ) makes it easy to ... to monitor or control unsanitary reuse ... gamma-radiation-resistant, nonvolatile (NV) 1-Wire® memory. ... http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html , Maxim,s ...
(Date:5/27/2015)... May 27, 2015 In a new ... Canadian International Pharmacy Association (CIPA) found continued ... licensed Canadian pharmacies. Approximately 64% of respondents purchase some ... a non-U.S. pharmacy due to costs of filling ... under their insurance plan.   Many news ...
(Date:5/27/2015)... May 27, 2015  Genomic Health, Inc. (Nasdaq: GHDX ... Officer and Chief Financial Officer, will present at the Jefferies ... on Monday, June 1 at 8:30 a.m. Eastern ... archived webcast of the presentation, go to the  Investor Relations ... Please connect to the web site at least 15 minutes ...
Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3
... , Feb. 17 /PRNewswire / -- SI-BONE, Inc. ( ... use of a minimally invasive surgical device to treat sacroiliac (SI) ... joined the Company,s Medical Advisory Board.  Drs. Frank M. Phillips ... join Drs. Steven R. Garfin (chair), Mark ...
... SAN DIEGO , Feb. 17 Hollis-Eden Pharmaceuticals, ... its name to Harbor BioSciences, Inc. and that its ticker symbol ... 2010 . The company also received a new CUSIP number (41150V ... begin 2010 with a targeted business strategy focused on attaining proof-of-concept ...
Cached Medicine Technology:Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONE's Medical Advisory Board 2Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONE's Medical Advisory Board 3Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONE's Medical Advisory Board 4Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR' 2Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR' 3
(Date:5/27/2015)... Genius Monkey is pleased to announce ... technology, they have boosted sales for the Utah Honda ... level for seven Utah-based dealers. , Until recently, ... radio media. In 2014 the Utah Honda dealers changed ... Genius Monkey , shifted their marketing campaigns more towards ...
(Date:5/27/2015)... 27, 2015 With InnerVoice Communication App ... where the message is not only heard but seen -- ... virtually any motivating image. This award-winning and affordable app takes ... , Now, using InnerVoice Sender app in conjunction ... to a learner remotely for no additional cost. , ...
(Date:5/27/2015)... May 27, 2015 With a prevalently ... poll conducted during the "ACA - Controlling the Chaos" ... 75% are currently in the process of researching ... were confidently prepared for the reporting mandates. , According ... the webinar, those who are currently vetting ACA reporting ...
(Date:5/27/2015)... May 27, 2015 SmarterSkin, http://www.smarterskindermatology.com , ... a cutting-edge test that makes it easier for patients to ... type. , Dr. Sejal Shah is a cosmetic dermatologist ... NYC to offer the test. This revolutionary DNA test uses ... with skin aging: , 1. Firmness and elasticity ...
(Date:5/27/2015)... 2015 Decorview , a leading ... offering free design advice to homeowners looking to , ... “Light pollution caused by streetlights, outdoor signs, full moons ... sleep, said Kim Rush, VP of sales and merchandising ... North America with recently installed LED streetlights– the blue ...
Breaking Medicine News(10 mins):Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:Decorview Helps Homeowners Combat Light Pollution 2
... wore acupressure wristbands had much less nausea while receiving ... to anti-nausea medication, according to a study published in ... by University of Rochester Medical Center researchers. , ... essentially, an outcome related to your body that you ...
... Applications Show Individuals How Much They Will Pay ... and Improve Their HealthcareANN ARBOR, Mich., April 8 ... healthcare and its cost, employers and health insurers ... beneficiaries make well-informed decisions about their health and ...
... PHILADELPHIA, April 8 Kyle,s Treehouse -- an ... initiative for Autism Awareness Month: Autism151, 150 ... on the positive side of the autism experience by creating ... inspiration and success with one another, giving them even more ...
... Tax Would Raise Critical Funds for State Tobacco Prevention ... products - including spit and chew tobacco and flavored ... should be taxed at the same rate as cigarettes ... today by a coalition of public health organizations.(Logo: ...
... half of non-smoking New Yorkers have elevated levels of ... recently exposed to toxic second-hand smoke in concentrations high ... by-product of nicotine breakdown, is not harmful itself but ... study, published online this week in the journal ...
... Meeting of the European Society of Cardiology Council on ... with the Irish Nurses Cardiovascular Association (INCA), is being ... 24-25 April. , The meeting - considered by ... and allied health professionals - will show case the ...
Cached Medicine News:Health News:Wristbands ease nausea with cancer treatment 2Health News:HealthEquity, a Leading Healthcare Account Administrator, Licenses Thomson Reuters Information Solutions to Help People Make Better Healthcare Decisions 2Health News:HealthEquity, a Leading Healthcare Account Administrator, Licenses Thomson Reuters Information Solutions to Help People Make Better Healthcare Decisions 3Health News:Kyle's Treehouse Launches Autism151.com for Autism Awareness Month 2Health News:New Ohio Ad Campaign Calls for Taxing All Tobacco Products at Same Rate 2Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 2Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 3Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 4Health News:Telemonitoring changes the working practice of cardiac nurses 2Health News:Telemonitoring changes the working practice of cardiac nurses 3Health News:Telemonitoring changes the working practice of cardiac nurses 4Health News:Telemonitoring changes the working practice of cardiac nurses 5Health News:Telemonitoring changes the working practice of cardiac nurses 6
... The SYNCHRON CX9 ALX system is ... time-consuming manual processes by as much as ... lower your total costs. Featuring the AccuSense® ... and an expanded test menu, the CX9 ...
... for the mid- to high-volume lab, the ... can reduce time-consuming manual tasks by as ... performs random access, STAT, HCFA panels and ... including Stat chemistries, General chemistries, TDMs, DATs, ...
... It takes powerful technology to ... safety, and still lower costs. ... LX20 PRO, offering features that ... any other chemistry analyzer, including ...
... This user-friendly instrument is ... Protein analyzer for the ... is a well established ... results for a wide ...
Medicine Products: